Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

NCT00040573

Conditions: Brain Diseases, Brain Neoplasm, Brain Neoplasms, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Saint Louis University St Louis, Missouri, United States

View Trial Details

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

NCT00043368

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
Locations: Pfizer Investigational Site Berkely, California, United States

Pfizer Investigational Site Gilroy, California, United States

Pfizer Investigational Site Hollister, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View all 32 locations

View Trial Details

Completed

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

NCT00095108

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

NCT00243594

Conditions: Melanoma, Melanoma Stage III or IV, Neoplasms, +10 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, PO Box 9101, Netherlands

View Trial Details

Completed

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

NCT00847106

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

NCT00152126

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

CPG 7909 Injection in Melanoma

NCT00070642

Conditions: Carcinoma, Carcinoma, Melanoma, Melanoma, +12 more
Locations: Not specified

View Trial Details

Completed

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

NCT00004892

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Emory University Hospital - Atlanta Atlanta, Georgia, United States

Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Carmustine in Treating Patients With Recurrent Malignant Glioma

NCT00004028

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Emory University Hospital - Atlanta Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

NCT00045474

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions